Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma - Henry, D H; Costa, L; Goldwasser, F (J Clin Oncol, 2011)
et al.